Hennessy Advisors Inc Moderna, Inc. Transaction History

Hennessy Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$96.41 - $126.61 $38,564 - $50,644	-400 Reduced 2.53%	15,400 $1.59 Million
Q2 2023 Jul 17, 2023	SELL	$118.5 - $160.53 $47,400 - $64,212	-400 Reduced 2.47%	15,800 $1.92 Million
Q1 2023 Apr 14, 2023	SELL	$135.66 - $197.02 $67,830 - $98,510	-500 Reduced 2.99%	16,200 $2.49 Million
Q4 2022 Jan 20, 2023	SELL	$118.38 - $210.04 $118,380 - $210,040	-1,000 Reduced 5.65%	16,700 $3 Million
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $47,228 - $77,672	-400 Reduced 2.21%	17,700 $2.09 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $46,852 - $70,636	-400 Reduced 2.16%	18,100 $2.59 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $2.34 Million - $4.35 Million	18,500 New	18,500 $3.19 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Hennessy Advisors Inc with notifications on news.